Bone Marrow Transplant - Global Market Outlook (2015-2022)
According to Stratistics MRC, the Bone Marrow Transplant market accounted for $10.58 billion in 2015 and is expected to reach $15.95 billion by 2022 growing at a CAGR of 6.0% from 2015 to 2022. Occurrence of blood cancers and increasing investment in logistic services are the key factors fueling the market growth. On the other hand, high cost of the treatment and uncertainty of reimbursement in several developing countries are the key factors hampering the market growth.
With more than 60% of the total market share in 2014, Autologous segment leads the global bone marrow transplant market due to the less considerable side effects. Allogeneic is anticipated to grow at the highest CAGR during the forecast period. Europe dominated the global market for bone marrow transplant accounting for more than 50% of the market revenue followed by North America.
Some of the key players in the market include Lonza Group Ltd., Cellular Dynamics International, Merck Millipore Corporation, ABM Industries, Inc., HemaCare Corporation, ReachBio LLC, American Type Culture Collection (ATCC) Inc., Conversant Biologics, Inc., PromoCell GmbH, Sanofi-Aventis LLC, AllCells, LLC, Mesoblast Limited, STEMCELL Technologies Inc. and Lifeline Cell Technology.
Disease Indication Covered:
WHAT OUR REPORT OFFERS:
With more than 60% of the total market share in 2014, Autologous segment leads the global bone marrow transplant market due to the less considerable side effects. Allogeneic is anticipated to grow at the highest CAGR during the forecast period. Europe dominated the global market for bone marrow transplant accounting for more than 50% of the market revenue followed by North America.
Some of the key players in the market include Lonza Group Ltd., Cellular Dynamics International, Merck Millipore Corporation, ABM Industries, Inc., HemaCare Corporation, ReachBio LLC, American Type Culture Collection (ATCC) Inc., Conversant Biologics, Inc., PromoCell GmbH, Sanofi-Aventis LLC, AllCells, LLC, Mesoblast Limited, STEMCELL Technologies Inc. and Lifeline Cell Technology.
Disease Indication Covered:
- Blood Cancer
- Lymphoma
- Myelodysplastic Syndrome
- Myeloma
- Solid Tumors
- Myeloproliferative Neoplasms
- Leukemia
- Blood Disorders
- Sickle cell anemia
- Aplastic anemia
- Thalassemia
- Allogeneic Bone Marrow Transplant
- Autologous Bone Marrow Transplant
- Multispecialty Clinics
- Hospitals
- Ambulatory Surgery Centers
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- Italy
- UK
- Spain
- Rest of Europe
- Asia Pacific
- Japan
- China
- India
- Australia
- New Zealand
- Rest of Asia Pacific
- Rest of the World
- Middle East
- Brazil
- Argentina
- South Africa
- Egypt
WHAT OUR REPORT OFFERS:
- Market share assessments for the regional and country level segments
- Market share analysis of the top industry players
- Strategic recommendations for the new entrants
- Market forecasts for a minimum of 7 years of all the mentioned segments, sub segments and the regional markets
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements
1 EXECUTIVE SUMMARY
2 PREFACE
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 MARKET TREND ANALYSIS
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 End User Analysis
3.7 Emerging Markets
4 PORTERS FIVE FORCE ANALYSIS
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 GLOBAL BONE MARROW TRANSPLANT MARKET, BY DISEASE INDICATION
5.1 Introduction
5.2 Blood Cancer
5.2.1 Lymphoma
5.2.2 Myelodysplastic Syndrome
5.2.3 Myeloma
5.2.4 Solid Tumors
5.2.5 Myeloproliferative Neoplasms
5.2.6 Leukemia
5.3 Blood Disorders
5.3.1 Sickle cell anemia
5.3.2 Aplastic anemia
5.3.3 Thalassemia
6 GLOBAL BONE MARROW TRANSPLANT MARKET, BY TRANSPLANT TYPE
6.1 Introduction
6.2 Allogeneic Bone Marrow Transplant
6.3 Autologous Bone Marrow Transplant
7 GLOBAL BONE MARROW TRANSPLANT MARKET, BY END USER
7.1 Introduction
7.2 Multispecialty Clinics
7.3 Hospitals
7.4 Ambulatory Surgery Centers
8 GLOBAL BONE MARROW TRANSPLANT MARKET, BY GEOGRAPHY
8.1 North America
8.1.1 US
8.1.2 Canada
8.1.3 Mexico
8.2 Europe
8.2.1 Germany
8.2.2 France
8.2.3 Italy
8.2.4 UK
8.2.5 Spain
8.2.6 Rest of Europe
8.3 Asia Pacific
8.3.1 Japan
8.3.2 China
8.3.3 India
8.3.4 Australia
8.3.5 New Zealand
8.3.6 Rest of Asia Pacific
8.4 Rest of the World
8.4.1 Middle East
8.4.2 Brazil
8.4.3 Argentina
8.4.4 South Africa
8.4.5 Egypt
9 KEY DEVELOPMENTS
9.1 Agreements, Partnerships, Collaborations and Joint Ventures
9.2 Acquisitions & Mergers
9.3 New Product Launch
9.4 Expansions
9.5 Other Key Strategies
10 COMPANY PROFILING
10.1 Lonza Group Ltd.
10.2 Cellular Dynamics International
10.3 Merck Millipore Corporation
10.4 ABM Industries, Inc.
10.5 HemaCare Corporation
10.6 ReachBio LLC
10.7 American Type Culture Collection (ATCC) Inc.
10.8 Conversant Biologics, Inc.
10.9 PromoCell GmbH
10.10 Sanofi-Aventis LLC
10.11 AllCells, LLC
10.12 Mesoblast Limited
10.13 STEMCELL Technologies Inc.
10.14 Lifeline Cell Technology
2 PREFACE
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 MARKET TREND ANALYSIS
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 End User Analysis
3.7 Emerging Markets
4 PORTERS FIVE FORCE ANALYSIS
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 GLOBAL BONE MARROW TRANSPLANT MARKET, BY DISEASE INDICATION
5.1 Introduction
5.2 Blood Cancer
5.2.1 Lymphoma
5.2.2 Myelodysplastic Syndrome
5.2.3 Myeloma
5.2.4 Solid Tumors
5.2.5 Myeloproliferative Neoplasms
5.2.6 Leukemia
5.3 Blood Disorders
5.3.1 Sickle cell anemia
5.3.2 Aplastic anemia
5.3.3 Thalassemia
6 GLOBAL BONE MARROW TRANSPLANT MARKET, BY TRANSPLANT TYPE
6.1 Introduction
6.2 Allogeneic Bone Marrow Transplant
6.3 Autologous Bone Marrow Transplant
7 GLOBAL BONE MARROW TRANSPLANT MARKET, BY END USER
7.1 Introduction
7.2 Multispecialty Clinics
7.3 Hospitals
7.4 Ambulatory Surgery Centers
8 GLOBAL BONE MARROW TRANSPLANT MARKET, BY GEOGRAPHY
8.1 North America
8.1.1 US
8.1.2 Canada
8.1.3 Mexico
8.2 Europe
8.2.1 Germany
8.2.2 France
8.2.3 Italy
8.2.4 UK
8.2.5 Spain
8.2.6 Rest of Europe
8.3 Asia Pacific
8.3.1 Japan
8.3.2 China
8.3.3 India
8.3.4 Australia
8.3.5 New Zealand
8.3.6 Rest of Asia Pacific
8.4 Rest of the World
8.4.1 Middle East
8.4.2 Brazil
8.4.3 Argentina
8.4.4 South Africa
8.4.5 Egypt
9 KEY DEVELOPMENTS
9.1 Agreements, Partnerships, Collaborations and Joint Ventures
9.2 Acquisitions & Mergers
9.3 New Product Launch
9.4 Expansions
9.5 Other Key Strategies
10 COMPANY PROFILING
10.1 Lonza Group Ltd.
10.2 Cellular Dynamics International
10.3 Merck Millipore Corporation
10.4 ABM Industries, Inc.
10.5 HemaCare Corporation
10.6 ReachBio LLC
10.7 American Type Culture Collection (ATCC) Inc.
10.8 Conversant Biologics, Inc.
10.9 PromoCell GmbH
10.10 Sanofi-Aventis LLC
10.11 AllCells, LLC
10.12 Mesoblast Limited
10.13 STEMCELL Technologies Inc.
10.14 Lifeline Cell Technology
LIST OF TABLES
1 Global Bone Marrow Transplant Market Outlook, By Region (2013-2022) ($MN)
2 Global Bone Marrow Transplant Market Outlook, By Disease Indication (2013-2022) ($MN)
3 Global Bone Marrow Transplant Market Outlook, By Blood Cancer (2013-2022) ($MN)
4 Global Bone Marrow Transplant Market Outlook, By Lymphoma (2013-2022) ($MN)
5 Global Bone Marrow Transplant Market Outlook, By Myelodysplastic Syndrome (2013-2022) ($MN)
6 Global Bone Marrow Transplant Market Outlook, By Myeloma (2013-2022) ($MN)
7 Global Bone Marrow Transplant Market Outlook, By Solid Tumors (2013-2022) ($MN)
8 Global Bone Marrow Transplant Market Outlook, By Myeloproliferative Neoplasms (2013-2022) ($MN)
9 Global Bone Marrow Transplant Market Outlook, By Leukemia (2013-2022) ($MN)
10 Global Bone Marrow Transplant Market Outlook, By Blood Disorders (2013-2022) ($MN)
11 Global Bone Marrow Transplant Market Outlook, By Sickle cell anemia (2013-2022) ($MN)
12 Global Bone Marrow Transplant Market Outlook, By Aplastic Anemia (2013-2022) ($MN)
13 Global Bone Marrow Transplant Market Outlook, By Thalassemia (2013-2022) ($MN)
14 Global Bone Marrow Transplant Market Outlook, By Transplant Type (2013-2022) ($MN)
15 Global Bone Marrow Transplant Market Outlook, By Allogeneic Bone Marrow Transplant (2013-2022) ($MN)
16 Global Bone Marrow Transplant Market Outlook, By Autologous Bone Marrow Transplant (2013-2022) ($MN)
17 Global Bone Marrow Transplant Market Outlook, By End User (2013-2022) ($MN)
18 Global Bone Marrow Transplant Market Outlook, By Multispecialty Clinics (2013-2022) ($MN)
19 Global Bone Marrow Transplant Market Outlook, By Hospitals (2013-2022) ($MN)
20 Global Bone Marrow Transplant Market Outlook, By Ambulatory Surgery Centers (2013-2022) ($MN)
21 North America Bone Marrow Transplant Market Outlook, By Country (2013-2022) ($MN)
22 North America Bone Marrow Transplant Market Outlook, By Disease Indication (2013-2022) ($MN)
23 North America Bone Marrow Transplant Market Outlook, By Blood Cancer (2013-2022) ($MN)
24 North America Bone Marrow Transplant Market Outlook, By Lymphoma (2013-2022) ($MN)
25 North America Bone Marrow Transplant Market Outlook, By Myelodysplastic Syndrome (2013-2022) ($MN)
26 North America Bone Marrow Transplant Market Outlook, By Myeloma (2013-2022) ($MN)
27 North America Bone Marrow Transplant Market Outlook, By Solid Tumors (2013-2022) ($MN)
28 North America Bone Marrow Transplant Market Outlook, By Myeloproliferative Neoplasms (2013-2022) ($MN)
29 North America Bone Marrow Transplant Market Outlook, By Leukemia (2013-2022) ($MN)
30 North America Bone Marrow Transplant Market Outlook, By Blood Disorders (2013-2022) ($MN)
31 North America Bone Marrow Transplant Market Outlook, By Sickle cell anemia (2013-2022) ($MN)
32 North America Bone Marrow Transplant Market Outlook, By Aplastic Anemia (2013-2022) ($MN)
33 North America Bone Marrow Transplant Market Outlook, By Thalassemia (2013-2022) ($MN)
34 North America Bone Marrow Transplant Market Outlook, By Transplant Type (2013-2022) ($MN)
35 North America Bone Marrow Transplant Market Outlook, By Allogeneic Bone Marrow Transplant (2013-2022) ($MN)
36 North America Bone Marrow Transplant Market Outlook, By Autologous Bone Marrow Transplant (2013-2022) ($MN)
37 North America Bone Marrow Transplant Market Outlook, By End User (2013-2022) ($MN)
38 North America Bone Marrow Transplant Market Outlook, By Multispecialty Clinics (2013-2022) ($MN)
39 North America Bone Marrow Transplant Market Outlook, By Hospitals (2013-2022) ($MN)
40 North America Bone Marrow Transplant Market Outlook, By Ambulatory Surgery Centers (2013-2022) ($MN)
41 Europe Bone Marrow Transplant Market Outlook, By Country (2013-2022) ($MN)
42 Europe Bone Marrow Transplant Market Outlook, By Disease Indication (2013-2022) ($MN)
43 Europe Bone Marrow Transplant Market Outlook, By Blood Cancer (2013-2022) ($MN)
44 Europe Bone Marrow Transplant Market Outlook, By Lymphoma (2013-2022) ($MN)
45 Europe Bone Marrow Transplant Market Outlook, By Myelodysplastic Syndrome (2013-2022) ($MN)
46 Europe Bone Marrow Transplant Market Outlook, By Myeloma (2013-2022) ($MN)
47 Europe Bone Marrow Transplant Market Outlook, By Solid Tumors (2013-2022) ($MN)
48 Europe Bone Marrow Transplant Market Outlook, By Myeloproliferative Neoplasms (2013-2022) ($MN)
49 Europe Bone Marrow Transplant Market Outlook, By Leukemia (2013-2022) ($MN)
50 Europe Bone Marrow Transplant Market Outlook, By Blood Disorders (2013-2022) ($MN)
51 Europe Bone Marrow Transplant Market Outlook, By Sickle cell anemia (2013-2022) ($MN)
52 Europe Bone Marrow Transplant Market Outlook, By Aplastic Anemia (2013-2022) ($MN)
53 Europe Bone Marrow Transplant Market Outlook, By Thalassemia (2013-2022) ($MN)
54 Europe Bone Marrow Transplant Market Outlook, By Transplant Type (2013-2022) ($MN)
55 Europe Bone Marrow Transplant Market Outlook, By Allogeneic Bone Marrow Transplant (2013-2022) ($MN)
56 Europe Bone Marrow Transplant Market Outlook, By Autologous Bone Marrow Transplant (2013-2022) ($MN)
57 Europe Bone Marrow Transplant Market Outlook, By End User (2013-2022) ($MN)
58 Europe Bone Marrow Transplant Market Outlook, By Multispecialty Clinics (2013-2022) ($MN)
59 Europe Bone Marrow Transplant Market Outlook, By Hospitals (2013-2022) ($MN)
60 Europe Bone Marrow Transplant Market Outlook, By Ambulatory Surgery Centers (2013-2022) ($MN)
61 Asia Pacific Bone Marrow Transplant Market Outlook, By Country (2013-2022) ($MN)
62 Asia Pacific Bone Marrow Transplant Market Outlook, By Disease Indication (2013-2022) ($MN)
63 Asia Pacific Bone Marrow Transplant Market Outlook, By Blood Cancer (2013-2022) ($MN)
64 Asia Pacific Bone Marrow Transplant Market Outlook, By Lymphoma (2013-2022) ($MN)
65 Asia Pacific Bone Marrow Transplant Market Outlook, By Myelodysplastic Syndrome (2013-2022) ($MN)
66 Asia Pacific Bone Marrow Transplant Market Outlook, By Myeloma (2013-2022) ($MN)
67 Asia Pacific Bone Marrow Transplant Market Outlook, By Solid Tumors (2013-2022) ($MN)
68 Asia Pacific Bone Marrow Transplant Market Outlook, By Myeloproliferative Neoplasms (2013-2022) ($MN)
69 Asia Pacific Bone Marrow Transplant Market Outlook, By Leukemia (2013-2022) ($MN)
70 Asia Pacific Bone Marrow Transplant Market Outlook, By Blood Disorders (2013-2022) ($MN)
71 Asia Pacific Bone Marrow Transplant Market Outlook, By Sickle cell anemia (2013-2022) ($MN)
72 Asia Pacific Bone Marrow Transplant Market Outlook, By Aplastic Anemia (2013-2022) ($MN)
73 Asia Pacific Bone Marrow Transplant Market Outlook, By Thalassemia (2013-2022) ($MN)
74 Asia Pacific Bone Marrow Transplant Market Outlook, By Transplant Type (2013-2022) ($MN)
75 Asia Pacific Bone Marrow Transplant Market Outlook, By Allogeneic Bone Marrow Transplant (2013-2022) ($MN)
76 Asia Pacific Bone Marrow Transplant Market Outlook, By Autologous Bone Marrow Transplant (2013-2022) ($MN)
77 Asia Pacific Bone Marrow Transplant Market Outlook, By End User (2013-2022) ($MN)
78 Asia Pacific Bone Marrow Transplant Market Outlook, By Multispecialty Clinics (2013-2022) ($MN)
79 Asia Pacific Bone Marrow Transplant Market Outlook, By Hospitals (2013-2022) ($MN)
80 Asia Pacific Bone Marrow Transplant Market Outlook, By Ambulatory Surgery Centers (2013-2022) ($MN)
81 RoW Bone Marrow Transplant Market Outlook, By Country (2013-2022) ($MN)
82 RoW Bone Marrow Transplant Market Outlook, By Disease Indication (2013-2022) ($MN)
83 RoW Bone Marrow Transplant Market Outlook, By Blood Cancer (2013-2022) ($MN)
84 RoW Bone Marrow Transplant Market Outlook, By Lymphoma (2013-2022) ($MN)
85 RoW Bone Marrow Transplant Market Outlook, By Myelodysplastic Syndrome (2013-2022) ($MN)
86 RoW Bone Marrow Transplant Market Outlook, By Myeloma (2013-2022) ($MN)
87 RoW Bone Marrow Transplant Market Outlook, By Solid Tumors (2013-2022) ($MN)
88 RoW Bone Marrow Transplant Market Outlook, By Myeloproliferative Neoplasms (2013-2022) ($MN)
89 RoW Bone Marrow Transplant Market Outlook, By Leukemia (2013-2022) ($MN)
90 RoW Bone Marrow Transplant Market Outlook, By Blood Disorders (2013-2022) ($MN)
91 RoW Bone Marrow Transplant Market Outlook, By Sickle cell anemia (2013-2022) ($MN)
92 RoW Bone Marrow Transplant Market Outlook, By Aplastic Anemia (2013-2022) ($MN)
93 RoW Bone Marrow Transplant Market Outlook, By Thalassemia (2013-2022) ($MN)
94 RoW Bone Marrow Transplant Market Outlook, By Transplant Type (2013-2022) ($MN)
95 RoW Bone Marrow Transplant Market Outlook, By Allogeneic Bone Marrow Transplant (2013-2022) ($MN)
96 RoW Bone Marrow Transplant Market Outlook, By Autologous Bone Marrow Transplant (2013-2022) ($MN)
97 RoW Bone Marrow Transplant Market Outlook, By End User (2013-2022) ($MN)
98 RoW Bone Marrow Transplant Market Outlook, By Multispecialty Clinics (2013-2022) ($MN)
99 RoW Bone Marrow Transplant Market Outlook, By Hospitals (2013-2022) ($MN)
100 RoW Bone Marrow Transplant Market Outlook, By Ambulatory Surgery Centers (2013-2022) ($MN)
1 Global Bone Marrow Transplant Market Outlook, By Region (2013-2022) ($MN)
2 Global Bone Marrow Transplant Market Outlook, By Disease Indication (2013-2022) ($MN)
3 Global Bone Marrow Transplant Market Outlook, By Blood Cancer (2013-2022) ($MN)
4 Global Bone Marrow Transplant Market Outlook, By Lymphoma (2013-2022) ($MN)
5 Global Bone Marrow Transplant Market Outlook, By Myelodysplastic Syndrome (2013-2022) ($MN)
6 Global Bone Marrow Transplant Market Outlook, By Myeloma (2013-2022) ($MN)
7 Global Bone Marrow Transplant Market Outlook, By Solid Tumors (2013-2022) ($MN)
8 Global Bone Marrow Transplant Market Outlook, By Myeloproliferative Neoplasms (2013-2022) ($MN)
9 Global Bone Marrow Transplant Market Outlook, By Leukemia (2013-2022) ($MN)
10 Global Bone Marrow Transplant Market Outlook, By Blood Disorders (2013-2022) ($MN)
11 Global Bone Marrow Transplant Market Outlook, By Sickle cell anemia (2013-2022) ($MN)
12 Global Bone Marrow Transplant Market Outlook, By Aplastic Anemia (2013-2022) ($MN)
13 Global Bone Marrow Transplant Market Outlook, By Thalassemia (2013-2022) ($MN)
14 Global Bone Marrow Transplant Market Outlook, By Transplant Type (2013-2022) ($MN)
15 Global Bone Marrow Transplant Market Outlook, By Allogeneic Bone Marrow Transplant (2013-2022) ($MN)
16 Global Bone Marrow Transplant Market Outlook, By Autologous Bone Marrow Transplant (2013-2022) ($MN)
17 Global Bone Marrow Transplant Market Outlook, By End User (2013-2022) ($MN)
18 Global Bone Marrow Transplant Market Outlook, By Multispecialty Clinics (2013-2022) ($MN)
19 Global Bone Marrow Transplant Market Outlook, By Hospitals (2013-2022) ($MN)
20 Global Bone Marrow Transplant Market Outlook, By Ambulatory Surgery Centers (2013-2022) ($MN)
21 North America Bone Marrow Transplant Market Outlook, By Country (2013-2022) ($MN)
22 North America Bone Marrow Transplant Market Outlook, By Disease Indication (2013-2022) ($MN)
23 North America Bone Marrow Transplant Market Outlook, By Blood Cancer (2013-2022) ($MN)
24 North America Bone Marrow Transplant Market Outlook, By Lymphoma (2013-2022) ($MN)
25 North America Bone Marrow Transplant Market Outlook, By Myelodysplastic Syndrome (2013-2022) ($MN)
26 North America Bone Marrow Transplant Market Outlook, By Myeloma (2013-2022) ($MN)
27 North America Bone Marrow Transplant Market Outlook, By Solid Tumors (2013-2022) ($MN)
28 North America Bone Marrow Transplant Market Outlook, By Myeloproliferative Neoplasms (2013-2022) ($MN)
29 North America Bone Marrow Transplant Market Outlook, By Leukemia (2013-2022) ($MN)
30 North America Bone Marrow Transplant Market Outlook, By Blood Disorders (2013-2022) ($MN)
31 North America Bone Marrow Transplant Market Outlook, By Sickle cell anemia (2013-2022) ($MN)
32 North America Bone Marrow Transplant Market Outlook, By Aplastic Anemia (2013-2022) ($MN)
33 North America Bone Marrow Transplant Market Outlook, By Thalassemia (2013-2022) ($MN)
34 North America Bone Marrow Transplant Market Outlook, By Transplant Type (2013-2022) ($MN)
35 North America Bone Marrow Transplant Market Outlook, By Allogeneic Bone Marrow Transplant (2013-2022) ($MN)
36 North America Bone Marrow Transplant Market Outlook, By Autologous Bone Marrow Transplant (2013-2022) ($MN)
37 North America Bone Marrow Transplant Market Outlook, By End User (2013-2022) ($MN)
38 North America Bone Marrow Transplant Market Outlook, By Multispecialty Clinics (2013-2022) ($MN)
39 North America Bone Marrow Transplant Market Outlook, By Hospitals (2013-2022) ($MN)
40 North America Bone Marrow Transplant Market Outlook, By Ambulatory Surgery Centers (2013-2022) ($MN)
41 Europe Bone Marrow Transplant Market Outlook, By Country (2013-2022) ($MN)
42 Europe Bone Marrow Transplant Market Outlook, By Disease Indication (2013-2022) ($MN)
43 Europe Bone Marrow Transplant Market Outlook, By Blood Cancer (2013-2022) ($MN)
44 Europe Bone Marrow Transplant Market Outlook, By Lymphoma (2013-2022) ($MN)
45 Europe Bone Marrow Transplant Market Outlook, By Myelodysplastic Syndrome (2013-2022) ($MN)
46 Europe Bone Marrow Transplant Market Outlook, By Myeloma (2013-2022) ($MN)
47 Europe Bone Marrow Transplant Market Outlook, By Solid Tumors (2013-2022) ($MN)
48 Europe Bone Marrow Transplant Market Outlook, By Myeloproliferative Neoplasms (2013-2022) ($MN)
49 Europe Bone Marrow Transplant Market Outlook, By Leukemia (2013-2022) ($MN)
50 Europe Bone Marrow Transplant Market Outlook, By Blood Disorders (2013-2022) ($MN)
51 Europe Bone Marrow Transplant Market Outlook, By Sickle cell anemia (2013-2022) ($MN)
52 Europe Bone Marrow Transplant Market Outlook, By Aplastic Anemia (2013-2022) ($MN)
53 Europe Bone Marrow Transplant Market Outlook, By Thalassemia (2013-2022) ($MN)
54 Europe Bone Marrow Transplant Market Outlook, By Transplant Type (2013-2022) ($MN)
55 Europe Bone Marrow Transplant Market Outlook, By Allogeneic Bone Marrow Transplant (2013-2022) ($MN)
56 Europe Bone Marrow Transplant Market Outlook, By Autologous Bone Marrow Transplant (2013-2022) ($MN)
57 Europe Bone Marrow Transplant Market Outlook, By End User (2013-2022) ($MN)
58 Europe Bone Marrow Transplant Market Outlook, By Multispecialty Clinics (2013-2022) ($MN)
59 Europe Bone Marrow Transplant Market Outlook, By Hospitals (2013-2022) ($MN)
60 Europe Bone Marrow Transplant Market Outlook, By Ambulatory Surgery Centers (2013-2022) ($MN)
61 Asia Pacific Bone Marrow Transplant Market Outlook, By Country (2013-2022) ($MN)
62 Asia Pacific Bone Marrow Transplant Market Outlook, By Disease Indication (2013-2022) ($MN)
63 Asia Pacific Bone Marrow Transplant Market Outlook, By Blood Cancer (2013-2022) ($MN)
64 Asia Pacific Bone Marrow Transplant Market Outlook, By Lymphoma (2013-2022) ($MN)
65 Asia Pacific Bone Marrow Transplant Market Outlook, By Myelodysplastic Syndrome (2013-2022) ($MN)
66 Asia Pacific Bone Marrow Transplant Market Outlook, By Myeloma (2013-2022) ($MN)
67 Asia Pacific Bone Marrow Transplant Market Outlook, By Solid Tumors (2013-2022) ($MN)
68 Asia Pacific Bone Marrow Transplant Market Outlook, By Myeloproliferative Neoplasms (2013-2022) ($MN)
69 Asia Pacific Bone Marrow Transplant Market Outlook, By Leukemia (2013-2022) ($MN)
70 Asia Pacific Bone Marrow Transplant Market Outlook, By Blood Disorders (2013-2022) ($MN)
71 Asia Pacific Bone Marrow Transplant Market Outlook, By Sickle cell anemia (2013-2022) ($MN)
72 Asia Pacific Bone Marrow Transplant Market Outlook, By Aplastic Anemia (2013-2022) ($MN)
73 Asia Pacific Bone Marrow Transplant Market Outlook, By Thalassemia (2013-2022) ($MN)
74 Asia Pacific Bone Marrow Transplant Market Outlook, By Transplant Type (2013-2022) ($MN)
75 Asia Pacific Bone Marrow Transplant Market Outlook, By Allogeneic Bone Marrow Transplant (2013-2022) ($MN)
76 Asia Pacific Bone Marrow Transplant Market Outlook, By Autologous Bone Marrow Transplant (2013-2022) ($MN)
77 Asia Pacific Bone Marrow Transplant Market Outlook, By End User (2013-2022) ($MN)
78 Asia Pacific Bone Marrow Transplant Market Outlook, By Multispecialty Clinics (2013-2022) ($MN)
79 Asia Pacific Bone Marrow Transplant Market Outlook, By Hospitals (2013-2022) ($MN)
80 Asia Pacific Bone Marrow Transplant Market Outlook, By Ambulatory Surgery Centers (2013-2022) ($MN)
81 RoW Bone Marrow Transplant Market Outlook, By Country (2013-2022) ($MN)
82 RoW Bone Marrow Transplant Market Outlook, By Disease Indication (2013-2022) ($MN)
83 RoW Bone Marrow Transplant Market Outlook, By Blood Cancer (2013-2022) ($MN)
84 RoW Bone Marrow Transplant Market Outlook, By Lymphoma (2013-2022) ($MN)
85 RoW Bone Marrow Transplant Market Outlook, By Myelodysplastic Syndrome (2013-2022) ($MN)
86 RoW Bone Marrow Transplant Market Outlook, By Myeloma (2013-2022) ($MN)
87 RoW Bone Marrow Transplant Market Outlook, By Solid Tumors (2013-2022) ($MN)
88 RoW Bone Marrow Transplant Market Outlook, By Myeloproliferative Neoplasms (2013-2022) ($MN)
89 RoW Bone Marrow Transplant Market Outlook, By Leukemia (2013-2022) ($MN)
90 RoW Bone Marrow Transplant Market Outlook, By Blood Disorders (2013-2022) ($MN)
91 RoW Bone Marrow Transplant Market Outlook, By Sickle cell anemia (2013-2022) ($MN)
92 RoW Bone Marrow Transplant Market Outlook, By Aplastic Anemia (2013-2022) ($MN)
93 RoW Bone Marrow Transplant Market Outlook, By Thalassemia (2013-2022) ($MN)
94 RoW Bone Marrow Transplant Market Outlook, By Transplant Type (2013-2022) ($MN)
95 RoW Bone Marrow Transplant Market Outlook, By Allogeneic Bone Marrow Transplant (2013-2022) ($MN)
96 RoW Bone Marrow Transplant Market Outlook, By Autologous Bone Marrow Transplant (2013-2022) ($MN)
97 RoW Bone Marrow Transplant Market Outlook, By End User (2013-2022) ($MN)
98 RoW Bone Marrow Transplant Market Outlook, By Multispecialty Clinics (2013-2022) ($MN)
99 RoW Bone Marrow Transplant Market Outlook, By Hospitals (2013-2022) ($MN)
100 RoW Bone Marrow Transplant Market Outlook, By Ambulatory Surgery Centers (2013-2022) ($MN)
